Cargando…

Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases

N6-methyladenosine (m6A) is a post-transcriptional RNA modification and one of the most abundant types of RNA chemical modifications. m6A functions as a molecular switch and is involved in a range of biomedical aspects, including cardiovascular diseases, the central nervous system, and cancers. Conc...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Yazhen, Fu, Yundong, Huang, Mingjie, Shen, Dandan, Zhao, Bing, Liu, Hongmin, Zheng, Yichao, Huang, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144293/ https://www.ncbi.nlm.nih.gov/pubmed/35628623 http://dx.doi.org/10.3390/ijms23105815

Ejemplares similares

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
por: Li, Zhonghua, et al.
Publicado: (2019)

Detailed resume of RNA m(6)A demethylases
por: Shen, Dandan, et al.
Publicado: (2022)

Chemical Biology of Lysine Demethylases
por: Heightman, Tom D
Publicado: (2011)

m6A demethylase FTO and osteoporosis: potential therapeutic interventions
por: Huang, Mei, et al.
Publicado: (2023)

Inhibitors of Protein Methyltransferases and Demethylases
por: Kaniskan, H. Ümit, et al.
Publicado: (2017)

The biological function of m6A demethylase ALKBH5 and its role in human disease
por: Wang, Jinyan, et al.
Publicado: (2020)

Rational Design and Optimization of m(6)A-RNA Demethylase FTO Inhibitors as Anticancer Agents
por: Huff, Sarah, et al.
Publicado: (2022)

Histone demethylases in chromatin biology and beyond
por: Dimitrova, Emilia, et al.
Publicado: (2015)

Recent Acquisition of Functional m6A RNA Demethylase Domain in Orchid Ty3/Gypsy Elements
por: Alvarado-Marchena, Luis, et al.
Publicado: (2022)

Omeprazole improves chemosensitivity of gastric cancer cells by m(6)A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation
por: Feng, Shuitu, et al.
Publicado: (2021)

Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
por: Qin, Bo, et al.
Publicado: (2022)

m(6)A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells
por: Huff, Sarah, et al.
Publicado: (2021)

RNA m(6)A demethylase ALKBH5 regulates the development of γδ T cells
por: Ding, Chenbo, et al.
Publicado: (2022)

m(6)A demethylase FTO regulate CTNNB1 to promote adipogenesis of chicken preadipocyte
por: Li, Kan, et al.
Publicado: (2022)

USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K/AKT Signaling Pathway
por: Sun, Jiangang, et al.
Publicado: (2020)

Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons
por: Selberg, Simona, et al.
Publicado: (2021)

Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
por: Selberg, Simona, et al.
Publicado: (2021)

Recent Advances in Chemical Biology of Mitochondria Targeting
por: Wang, Haiwei, et al.
Publicado: (2021)

Synthesis and Biological Activity of Sterol 14α-Demethylase and Sterol C24-Methyltransferase Inhibitors
por: Leaver, David J.
Publicado: (2018)

Inhibition of lysine-specific demethylase 1 (LSD1) prevented tumor growth and metastasis by downregulating PD-L1 expression in lung adenocarcinoma
por: He, Pengxing, et al.
Publicado: (2022)

Recent advances in dynamic m(6)A RNA modification
por: Cao, Guangchao, et al.
Publicado: (2016)

The role of m(6)A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse
por: Zhang, Zhi-Wei, et al.
Publicado: (2023)

KDM6 Demethylases and Their Roles in Human Cancers
por: Hua, Chunyan, et al.
Publicado: (2021)

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
por: Wu, Xianbo, et al.
Publicado: (2022)

Recent advances and limitations of mTOR inhibitors in the treatment of cancer
por: Ali, Eunus S., et al.
Publicado: (2022)

The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging
por: Jiang, Zhong-xin, et al.
Publicado: (2021)

Assessing histone demethylase inhibitors in cells: lessons learned
por: Hatch, Stephanie B., et al.
Publicado: (2017)

RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification
por: Li, Ran, et al.
Publicado: (2023)

Histone demethylases in the regulation of immunity and inflammation
por: Qu, Lihua, et al.
Publicado: (2023)

The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1
por: Ren, Shuai, et al.
Publicado: (2023)

A novel inhibitor of N(6)-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities
por: Xie, Guoyou, et al.
Publicado: (2022)

Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner
por: WANG, Zhenyu, et al.
Publicado: (2022)

m(6)A demethylase ALKBH5 controls CD4(+) T cell pathogenicity and promotes autoimmunity
por: Zhou, Jing, et al.
Publicado: (2021)

Correction: The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging
por: Jiang, Zhong-xin, et al.
Publicado: (2021)

A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1
por: Prusevich, Polina, et al.
Publicado: (2014)

Recent Advances in Scanning Electrochemical Microscopy for Biological Applications
por: Huang, Luyao, et al.
Publicado: (2018)

m(6)A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
por: Xiao, Dong, et al.
Publicado: (2021)

Recent advances in cohesin biology
por: Rankin, Susannah, et al.
Publicado: (2016)

Recent Advances in Scar Biology
por: Ogawa, Rei
Publicado: (2018)

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
por: Hu, Yiyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fct1o1ht0b2jt86ffdh9dpbuad